EDGAR Filing Documents for 0001144204-08-041996

Form 8-K - Current report:

SEC Accession No. 0001144204-08-041996

Filing Date

2008-07-28

Accepted

2008-07-25 17:34:44

Documents

Period of Report

2008-07-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		v120911_8k.htm	8-K	72988
2		v120911_ex4-1.htm	EX-4.1	70360
3		v120911_ex4-2.htm	EX-4.2	200969
4		v120911_ex10-1.htm	EX-10.1	66628
5		v120911_ex10-2.htm	EX-10.2	62888
6		v120911_ex10-3.htm	EX-10.3	54711
	Complete submission text file	0001144204-08-041996.txt		530492

Mailing Address 100 SOUTH MAIN STREET SUITE 300 DOYLESTOWN PA 18901

Business Address 100 SOUTH MAIN STREET SUITE 300 DOYLESTOWN PA 18901 267-880-1595

QUANTRX BIOMEDICAL CORP (Filer) CIK: 0000820608 (see all company filings)